paroxetine has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chuprun, JK; Feldman, AM; Gao, E; Koch, WJ; Schumacher, SM; Tesmer, JJ; Zhu, W | 1 |
| Ben-Izhak, O; Bishara, B; Carter, A; Edoute, Y; Fischer, D; Rozin, A | 1 |
2 other study(ies) available for paroxetine and Cirrhosis
| Article | Year |
|---|---|
Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Fibrosis; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Hemodynamics; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Paroxetine; Receptors, Adrenergic, beta; Translational Research, Biomedical; Ventricular Remodeling | 2015 |
Fibrosing omental panniculitis and polyserositis associated with long-term treatment by paroxetine.
Topics: Antidepressive Agents, Second-Generation; Drug Hypersensitivity; Female; Fibrosis; Humans; Middle Aged; Omentum; Panniculitis; Paroxetine; Peritoneal Diseases; Serositis | 2000 |